Can IV Infusions of Bone Marrow Derived Mesenchymal Stem Cell Extracellular Vesicles be the Fountain of Youth?
Journal Title: Journal of Regenerative Biology and Medicine - Year 2019, Vol 1, Issue 2
Abstract
There is increasing published literature to support the safety and efficacy of IV infusions of bone marrow-derived expanded allogeneic mesenchymal stem cells (MSCs) for the treatment of various auto-immune diseases. Frailty Syndrome was created to provide a way of objectively measuring aging with physical activity scales and bio-inflammatory markers. IV infusions of allogeneic MSCs have been reported to statistically significantly increase physical function and decrease inflammatory biomarkers in Frailty Syndrome. Replacing cellular allogeneic IV infusions with acellular bone marrow-derived MSC extracellular vesicle isolate products (EVIP) containing active growth factors (GFs) and exosomes has numerous advantages. Regenerative medicine researchers and clinicians now realize that living MSCs are not required to achieve clinical efficacy. The clinical efficacy of MSCs is due to their paracrine release of GFs and exosomes. Living MSCs are not required to accomplish the paracrine signaling of GFs and exosomes. Acellular MSC EVIP containing active GFs and exosomes are the future of regenerative medicine. Acellular exosomes derived from bone marrow MSCs provide a consistent product that has extensive characterization, which includes advanced particle analysis, proteomic evaluation and USP<71> sterility assurance. The future “Fountain of Youth†will be the frequent (3 to 4 times per year) IV infusion of bio pharmacologic quality bone marrow-derived MSC EVIP. These active GF and exosome infusions will result in a continual down regulation of systemic inflammation and based on published research reverse many of the inflammatory effects of aging.
Authors and Affiliations
Johnny East DO and Maxwell Dordevic*
Keywords
Related Articles
- EP ID EP707313
- DOI https://doi.org/10.37191/Mapsci-2582-385X-1(2)-010
- Views 90
- Downloads 0
Cardiology Clinic in COVID-19 Era Review Article
The outbreak of COVID-19 and succeeding lockdown curtailment of routine life activities resulted in a profound effect on healthcare systems, globally. There were difficulties in Outpatient follow-up during this time. Sin...
One of Curious Congenital Midline Abdominal Defects in Newborn: A Giant Omphalozele in a 3 Years-Old Boy
Omphalocele is one of the congenital abdominal wall defects and specifically refers to an umbilical ring defect in which the abdominal organs protrude in front of the abdominal wall in a thin sac or membrane. Such an abd...
HGH and Cartilage
Recombinant human growth hormone (rHGH) which plays an important role for remodeling of bone has an effect on cartilage differentiation and regeneration, as well. Herein, we reviewed human growth hormone and its roles on...
COVID-19 in Adults and Children: The Clock is Ticking
COVID-19 the world is shocked. Globally, 896450 confirmed cases and 45525 deaths (WHO, situation report 73, 2 April 2020) reveal that a viral agent is spreading in an exponential way all around the world with to date unk...
L-PRF in Osteoarthritis Treatment: Results of a Pilot Study
Osteoarthritis (OA) is the most common chronic musculoskeletal disorder and is the most frequent single cause of disability in older adults [1]. OA is a chronic disease progressively involving the entire joint. Progressi...